Vestibular SchwannomaNCT04057976
Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas
A study testing Probabilistic diffusion tensor tractography in people with Vestibular Schwannoma, run by King's College Hospital NHS Trust at 1 site in United Kingdom.
Trial summary
Vestibular schwannomas (VS) arise from the vestibulocochlear (hearing and balance) nerve, located at the base of the brain. Although benign, VS can enlarge over time, resulting in debilitating symptoms; therefore, surgical removal is frequently offered. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Vestibular Schwannoma
- What is being tested?
- Probabilistic diffusion tensor tractography
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 38 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 27 Jun 2019to 31 Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- The capacity to understand the patient information sheet and the ability to provide written informed consent
- >1.5cm extrameatal tumor determined to represent a vestibular schwannoma by preoperative imaging
- HB grade I or II preoperatively
Who cannot join
- Patients not meeting the above inclusion criteria
- Standard contraindications to MRI
- Previous cranial radiotherapy or previous surgery to the cerebellopontine angle cistern or IAM
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
King's College Hospital NHS Foundation Trust
London, London, SE5 9RS
About this study
Official title: The Accuracy of Advanced Probabilistic Diffusion Tensor Tractography (DTT) for the Pre-operative Identification of Facial Nerve Position in Patients With Extrameatal Vestibular Schwannomas.
Vestibular schwannomas (VS) arise from the vestibulocochlear (hearing and balance) nerve, located at the base of the brain. Although benign, VS can enlarge over time, resulting in debilitating symptoms; therefore, surgical removal is frequently offered. One significant risk of surgery is inadvertent injury to the facial nerve, which lies adjacent to the vestibulocochlear nerve. Currently, the nerve's course is only revealed during surgical dissection and injury can cause permanent facial weakness. It would therefore be useful for the surgeon to know the course of the nerve before operating. To this end, a new MRI technique known as probabilistic diffusion tensor tractography (DTT) has shown potential in revealing the course of the facial nerve pre-operatively. However, its clinical reliability remains uncertain.
This study aims to investigate the reliability of DTT in identifying the course of the facial nerve preoperatively in patients undergoing surgery for VS.
Read more
The future benefit would be to enable surgeons to operate with more confidence and potentially reduce the chance of nerve injury.
The study will recruit adult patients due to have surgery for VS. The only change to the participants' clinical pathways will be the addition of a DTT sequence to their pre-operative MRI scans (increasing scanning time by approximately 10 minutes).
Read the detailed description
BACKGROUND AND RATIONALE Vestibular schwannomas (VS) are peripheral nerve sheath tumours arising from the vestibulocochlear nerve, which emerges from the brainstem at the base of the brain and enters the structures of the inner ear via a small bony canal within the skull (internal auditory meatus). VS account for 8% (Johnson J et al.) of intracranial tumours and, although benign, these tumours can grow resulting in several potentially debilitating symptoms, including hearing loss, vertigo, tinnitus, facial paralysis and meningitis. Furthermore, large tumours may cause compression on the brainstem, which can, in some cases, have life-threatening consequences (Johnson J et al.). Therefore, patients diagnosed with larger tumours (>1.5cm extrameatal component) are frequently offered surgical resection (as opposed to conservative management or stereotactic radiosurgery). As surgical techniques have improved, the goal of surgery has broadened to include not only tumour removal, but also preservation of the function of the nerves involved by VS. In particular, surgical resection aims to preserve the function of the facial nerve, responsible for innervating the muscles of facial expression, and which runs alongside the vestibulocochlear nerve and is frequently displaced and flattened by VS. Given its juxtaposition, the facial nerve is at high risk of injury during surgery. Injury to the facial nerve (and consequent debilitating facial weakness or paralysis) is a serious potential risk of vestibular schwannoma (VS) surgery. However, at present, the only means of avoiding nerve injury involves a combination of meticulous surgical technique and the use of a facial nerve monitor (a device that can detect activity within the facial muscles when stimulated by a surgeon-held probe); however, despite this, facial nerve injury may still occur. Indeed, until the surgeon begins operating, the course of the facial nerve is unknown. In a large series (>1000 surgical cases) by Sampath et al., the position of the facial nerve position was found most commonly on the anterior middle portion of the tumour; however, in a smaller proportion of cases, the nerve lay in 1 of 7 additional locations (Sampath et al.). Therefore, it follows that preoperative detection and identification of the course of the facial nerve would be extremely useful to guide surgery and reduce the potential risk of neuronal injury.
There now exists a potential means of non-invasively identifying the course of the facial nerve using advanced applications of magnetic resonance imaging (MRI). This involves utilising a technique known as diffusion tensor tractography (DTT), which has the capacity to detect the direction (vector) of diffusivity in a particular volume of tissue (voxel) (Mukherjee et al.). This data can be subsequently used to reveal structures, such as nerve fibre tracts, that are arranged along particular vectors, enabling them to be differentiated from surrounding tissue (Cauley et al.). This cannot be achieved using standard MRI sequences, in which the flattened nerve often becomes indistinguishable from the adjacent VS. Fortunately, as MRI represents the current means of diagnosing and characterising VS, adding an additional DTT sequence to a patient's scan does not represent a significant burden (only approximately 10 additional minutes of scanning time to acquire the DTT data).
Several groups (Choi et al., Taoka et al., Gerganov et al., Zhang et al. and Song et al.) have used DTT to delineate the course of the facial nerve in patients with VS and the majority have reported high success rates (>90% agreement with operative findings). However, many of these studies employed 'deterministic' DTT, which has drawbacks that limit its reliability in the setting of small fibre tracts with complex geometry. In particular, it is unable to accurately track fibres that cross, split or merge because the technique assumes that adjacent voxels have similar vectors. In order to overcome these limitations, we propose using the newer 'probabilistic' DTT technique that calculates a vector for each voxel analysed. It therefore has the capacity to account for complex geometries, such as those encountered in the facial nerve, particularly where its course is heavily distorted by tumour tissue. Zolal et al. used this technique in 21 patients with VS, resulting in an agreement rate of 81% for the position of the facial nerve and 33% for the cochlear nerve (Zolal et al.). However, there is an ongoing need for further studies in this area.
This project seeks to clarify the accuracy, reproducibility and practicality of probabilistic DTT in locating the facial nerve pre-operatively. If the technique proves accurate, it will potentially help with pre-operative planning and avoidance of facial nerve injury during VS surgery. Additionally the project seeks to clarify associated practical issues; in particular, the inter-observer/intra-observer variability (i.e. whether the reading radiologists agree with each other and themselves when analysing DTT images), whether the facial nerve position can be partially inferred on conventional sequences (comparing this with DTT) and whether adjacent nerves (such as the vestibulocochlear nerve) can be identified, which may further help with surgical preoperative planning.
HYPOTHESIS:
It is hypothesised that preoperative advanced probabilistic diffusion tensor tractography (DTT) will accurately demonstrate the position of the facial nerve relative to extrameatal portion of a vestibular schwannoma. It is proposed that the accuracy will be superior to previous studies in which deterministic DTT has been used to demonstrate the position of the facial nerve. This pre-operative mapping has the potential to decrease the rates of facial nerve injury during vestibular schwannoma surgery and allow for increased resection of the tumour.
STUDY DESIGN:
Prospective cohort observational study.
For study eligibility and outcome measures, please see the relevant sections.
IMAGE ANALYSIS
MRI In addition to standard imaging assessment, further image analysis will be performed offline using MRTrix 3.0 (www.mrtrix.org) in tensor probabililty mode. The presence of one or more cranial nerve tracts will be determined by their consistent depiction following their systematic interrogation with varying anisotropy thresholds. There will be a qualitative assessment of cranial nerve position will be achieved by dividing the circumference of the extrameatal vestibular schwannoma into segments.The assessment will be performed by two observers.
Reference standard:
The position of the facial nerve with respect to the extrameatal portion of the vestibular schwannoma will be assessed at surgery will be achieved by dividing the circumference of the extrameatal vestibular schwannoma into multiple segments in the same manner as above. This assessment will be made independently of the results of the pre-operative probabilistic DTT (the neurosurgeon recording the data will be blinded to the DTT findings).
STATISTICAL CONSIDERATIONS
Sample size calculation:
Power calculation based upon a sample size of 32, assuming a true kappa coefficient of 0.9; the 95% confidence interval will have a width of 0.26 (0.77 - 1.03). The number (32) also reflects the number of cases that we expect to recruit over a 2-3 year period.
- Conditions
- Vestibular Schwannoma
- Being tested
- Probabilistic diffusion tensor tractography
- Medical subject headings
- Neuroma, Acoustic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Probabilistic diffusion tensor tractographyDiagnostic test
Patients enrolled in this study will undergo probabilistic diffusion tensor tractography (additional MRI sequence) preoperatively in order to determine whether this it is possible to determine the course of the facial nerve.
| Study group | Role | What they receive |
|---|---|---|
| Patients having pre-operative DTT prior to surgery | Experimental | All patients in this study will undergo DTT as part of a pre-operative MRI. Receives: Diagnostic Test: Probabilistic diffusion tensor tractography |
What is being measured
The primary outcome is the main question the study is designed to answer.
Accuracy of probabilistic diffusion tensor tractography (DTT)
To assess the accuracy of pre-operative probabilistic DTT in determining the position of the facial nerve (relative to extrameatal portion of a vestibular schwannoma) by using the facial nerve position at surgery as a reference standard.
Measured: 4 years
Secondary outcomes (6)
Reproducibility
To assess the interobserver and intraobserver reproducibility in the assessment of cranial nerve position on pre- operative probabilistic DTT images.
Measured: 4 years
Relationship of tumour size with confidence
To assess the relationship of tumour size with confidence when determining facial nerve position on pre-operative probabilistic DTT.
Measured: 4 years
Relationship of tumour size with accuracy
To assess the relationship of tumour size with accuracy when determining facial nerve position on pre-operative probabilistic DTT.
Measured: 4 years
Facial nerve shape
To compare the surgical assessment of facial nerve shape (compact or flat morphology, secondary to tumour-related pressure effects) with the ability to assess facial nerve position on pre-operative probabilistic DTT images.
Measured: 4 years
Comparison of DTT with conventional anatomical sequence
To compare the confidence and accuracy of pre-operative probabilistic DTT with high resolution T2w imaging (a standard anatomical MRI sequence obtained on routine pre-operative scanning) when determining facial nerve position.
Measured: 4 years
Assessment of adjacent CPA nerves.
To assess whether adjacent cranial nerves that lie at the cerebellopontine angle (base of the brain) and internal auditory meatus (inner ear canal) can be detected with pre-operative probabilistic DTT.
Measured: 4 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Aug 2019
- Study start27 Jun 2019
- Primary completion31 Dec 2024
- Study completion31 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (9)Papers the sponsor has linked to this study.
- Other trials for Vestibular SchwannomaStudies of the same condition, open and under way.
- More trials run by King's College Hospital NHS TrustThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 38 participants (actual)
Sponsor and investigators
- Lead sponsor
- King's College Hospital NHS Trust
- Sponsor type
- University, hospital or other
- Collaborators
- Guy's and St Thomas' NHS Foundation Trust
- Responsible party
- Sponsor
- Investigators
- Steve Connor, MBBS, FRCR, Principal investigator, King's College Hospital NHS Trust
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04057976
- Sponsor's protocol ID
- 226479
- Status last verified
- Oct 2024
- First submitted
- 11 Jul 2019
- Last updated
- 12 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Cauley KA, Filippi CG. Diffusion-tensor imaging of small nerve bundles: cranial nerves, peripheral nerves, distal spinal cord, and lumbar nerve roots--clinical applications. AJR Am J Roentgenol. 2013 Aug;201(2):W326-35. doi: 10.2214/AJR.12.9230.
PubMed 23883249Choi KS, Kim MS, Kwon HG, Jang SH, Kim OL. Preoperative identification of facial nerve in vestibular schwannomas surgery using diffusion tensor tractography. J Korean Neurosurg Soc. 2014 Jul;56(1):11-5. doi: 10.3340/jkns.2014.56.1.11. Epub 2014 Jul 31.
PubMed 25289119Gerganov VM, Giordano M, Samii M, Samii A. Diffusion tensor imaging-based fiber tracking for prediction of the position of the facial nerve in relation to large vestibular schwannomas. J Neurosurg. 2011 Dec;115(6):1087-93. doi: 10.3171/2011.7.JNS11495. Epub 2011 Aug 26.
PubMed 21962081Mukherjee P, Berman JI, Chung SW, Hess CP, Henry RG. Diffusion tensor MR imaging and fiber tractography: theoretic underpinnings. AJNR Am J Neuroradiol. 2008 Apr;29(4):632-41. doi: 10.3174/ajnr.A1051. Epub 2008 Mar 13.
PubMed 18339720Sampath P, Rini D, Long DM. Microanatomical variations in the cerebellopontine angle associated with vestibular schwannomas (acoustic neuromas): a retrospective study of 1006 consecutive cases. J Neurosurg. 2000 Jan;92(1):70-8. doi: 10.3171/jns.2000.92.1.0070.
PubMed 10616085Song F, Hou Y, Sun G, Chen X, Xu B, Huang JH, Zhang J. In vivo visualization of the facial nerve in patients with acoustic neuroma using diffusion tensor imaging-based fiber tracking. J Neurosurg. 2016 Oct;125(4):787-794. doi: 10.3171/2015.7.JNS142922. Epub 2016 Jan 1.
PubMed 26722859Taoka T, Hirabayashi H, Nakagawa H, Sakamoto M, Myochin K, Hirohashi S, Iwasaki S, Sakaki T, Kichikawa K. Displacement of the facial nerve course by vestibular schwannoma: preoperative visualization using diffusion tensor tractography. J Magn Reson Imaging. 2006 Nov;24(5):1005-10. doi: 10.1002/jmri.20725.
PubMed 17031835Zhang Y, Mao Z, Wei P, Jin Y, Ma L, Zhang J, Yu X. Preoperative Prediction of Location and Shape of Facial Nerve in Patients with Large Vestibular Schwannomas Using Diffusion Tensor Imaging-Based Fiber Tracking. World Neurosurg. 2017 Mar;99:70-78. doi: 10.1016/j.wneu.2016.11.110. Epub 2016 Nov 30.
PubMed 27915063Zolal A, Juratli TA, Podlesek D, Rieger B, Kitzler HH, Linn J, Schackert G, Sobottka SB. Probabilistic Tractography of the Cranial Nerves in Vestibular Schwannoma. World Neurosurg. 2017 Nov;107:47-53. doi: 10.1016/j.wneu.2017.07.102. Epub 2017 Jul 25.
PubMed 28754643
Study at a glance
From the registry record, last updated by the sponsor on 12 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Accuracy of Advanced Probabilistic Diffusion Tensor Tractography (DTT) for the Pre-operative Identification of Facial Nerve Position in Patients With Extrameatal Vestibular Schwannomas.
- ClinicalTrials.gov ID
- NCT04057976
- Acronym / sponsor ID
- 226479
- Conditions
- Vestibular Schwannoma
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 38 participants (actual)
- Lead sponsor
- King's College Hospital NHS TrustUniversity, hospital or other
- Collaborators
- Guy's and St Thomas' NHS Foundation Trust
- Study start
- 27 Jun 2019 (actual)
- Primary completion
- 31 Dec 2024 (actual)
- Study completion
- 31 Dec 2024 (actual)
- First posted
- 15 Aug 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Vestibular schwannomas (VS) arise from the vestibulocochlear (hearing and balance) nerve, located at the base of the brain. Although benign, VS can enlarge over time, resulting in debilitating symptoms; therefore, surgical removal is frequently offered. One significant risk of surgery is inadvertent injury to the facial nerve, which lies adjacent to the vestibulocochlear nerve. Currently, the nerve's course is only revealed during surgical dissection and injury can cause permanent facial weakness. It would therefore be useful for the surgeon to know the course of the nerve before operating. To this end, a new MRI technique known as probabilistic diffusion tensor tractography (DTT) has shown potential in revealing the course of the facial nerve pre-operatively. However, its clinical reliability remains uncertain.
This study aims to investigate the reliability of DTT in identifying the course of the facial nerve preoperatively in patients undergoing surgery for VS.
The future benefit would be to enable surgeons to operate with more confidence and potentially reduce the chance of nerve injury.
The study will recruit adult patients due to have surgery for VS. The only change to the participants' clinical pathways will be the addition of a DTT sequence to their pre-operative MRI scans (increasing scanning time by approximately 10 minutes).
Detailed description
BACKGROUND AND RATIONALE Vestibular schwannomas (VS) are peripheral nerve sheath tumours arising from the vestibulocochlear nerve, which emerges from the brainstem at the base of the brain and enters the structures of the inner ear via a small bony canal within the skull (internal auditory meatus). VS account for 8% (Johnson J et al.) of intracranial tumours and, although benign, these tumours can grow resulting in several potentially debilitating symptoms, including hearing loss, vertigo, tinnitus, facial paralysis and meningitis. Furthermore, large tumours may cause compression on the brainstem, which can, in some cases, have life-threatening consequences (Johnson J et al.). Therefore, patients diagnosed with larger tumours (>1.5cm extrameatal component) are frequently offered surgical resection (as opposed to conservative management or stereotactic radiosurgery). As surgical techniques have improved, the goal of surgery has broadened to include not only tumour removal, but also preservation of the function of the nerves involved by VS. In particular, surgical resection aims to preserve the function of the facial nerve, responsible for innervating the muscles of facial expression, and which runs alongside the vestibulocochlear nerve and is frequently displaced and flattened by VS. Given its juxtaposition, the facial nerve is at high risk of injury during surgery. Injury to the facial nerve (and consequent debilitating facial weakness or paralysis) is a serious potential risk of vestibular schwannoma (VS) surgery. However, at present, the only means of avoiding nerve injury involves a combination of meticulous surgical technique and the use of a facial nerve monitor (a device that can detect activity within the facial muscles when stimulated by a surgeon-held probe); however, despite this, facial nerve injury may still occur. Indeed, until the surgeon begins operating, the course of the facial nerve is unknown. In a large series (>1000 surgical cases) by Sampath et al., the position of the facial nerve position was found most commonly on the anterior middle portion of the tumour; however, in a smaller proportion of cases, the nerve lay in 1 of 7 additional locations (Sampath et al.). Therefore, it follows that preoperative detection and identification of the course of the facial nerve would be extremely useful to guide surgery and reduce the potential risk of neuronal injury.
There now exists a potential means of non-invasively identifying the course of the facial nerve using advanced applications of magnetic resonance imaging (MRI). This involves utilising a technique known as diffusion tensor tractography (DTT), which has the capacity to detect the direction (vector) of diffusivity in a particular volume of tissue (voxel) (Mukherjee et al.). This data can be subsequently used to reveal structures, such as nerve fibre tracts, that are arranged along particular vectors, enabling them to be differentiated from surrounding tissue (Cauley et al.). This cannot be achieved using standard MRI sequences, in which the flattened nerve often becomes indistinguishable from the adjacent VS. Fortunately, as MRI represents the current means of diagnosing and characterising VS, adding an additional DTT sequence to a patient's scan does not represent a significant burden (only approximately 10 additional minutes of scanning time to acquire the DTT data).
Several groups (Choi et al., Taoka et al., Gerganov et al., Zhang et al. and Song et al.) have used DTT to delineate the course of the facial nerve in patients with VS and the majority have reported high success rates (>90% agreement with operative findings). However, many of these studies employed 'deterministic' DTT, which has drawbacks that limit its reliability in the setting of small fibre tracts with complex geometry. In particular, it is unable to accurately track fibres that cross, split or merge because the technique assumes that adjacent voxels have similar vectors. In order to overcome these limitations, we propose using the newer 'probabilistic' DTT technique that calculates a vector for each voxel analysed. It therefore has the capacity to account for complex geometries, such as those encountered in the facial nerve, particularly where its course is heavily distorted by tumour tissue. Zolal et al. used this technique in 21 patients with VS, resulting in an agreement rate of 81% for the position of the facial nerve and 33% for the cochlear nerve (Zolal et al.). However, there is an ongoing need for further studies in this area.
This project seeks to clarify the accuracy, reproducibility and practicality of probabilistic DTT in locating the facial nerve pre-operatively. If the technique proves accurate, it will potentially help with pre-operative planning and avoidance of facial nerve injury during VS surgery. Additionally the project seeks to clarify associated practical issues; in particular, the inter-observer/intra-observer variability (i.e. whether the reading radiologists agree with each other and themselves when analysing DTT images), whether the facial nerve position can be partially inferred on conventional sequences (comparing this with DTT) and whether adjacent nerves (such as the vestibulocochlear nerve) can be identified, which may further help with surgical preoperative planning.
HYPOTHESIS:
It is hypothesised that preoperative advanced probabilistic diffusion tensor tractography (DTT) will accurately demonstrate the position of the facial nerve relative to extrameatal portion of a vestibular schwannoma. It is proposed that the accuracy will be superior to previous studies in which deterministic DTT has been used to demonstrate the position of the facial nerve. This pre-operative mapping has the potential to decrease the rates of facial nerve injury during vestibular schwannoma surgery and allow for increased resection of the tumour.
STUDY DESIGN:
Prospective cohort observational study.
For study eligibility and outcome measures, please see the relevant sections.
IMAGE ANALYSIS
MRI In addition to standard imaging assessment, further image analysis will be performed offline using MRTrix 3.0 (www.mrtrix.org) in tensor probabililty mode. The presence of one or more cranial nerve tracts will be determined by their consistent depiction following their systematic interrogation with varying anisotropy thresholds. There will be a qualitative assessment of cranial nerve position will be achieved by dividing the circumference of the extrameatal vestibular schwannoma into segments.The assessment will be performed by two observers.
Reference standard:
The position of the facial nerve with respect to the extrameatal portion of the vestibular schwannoma will be assessed at surgery will be achieved by dividing the circumference of the extrameatal vestibular schwannoma into multiple segments in the same manner as above. This assessment will be made independently of the results of the pre-operative probabilistic DTT (the neurosurgeon recording the data will be blinded to the DTT findings).
STATISTICAL CONSIDERATIONS
Sample size calculation:
Power calculation based upon a sample size of 32, assuming a true kappa coefficient of 0.9; the 95% confidence interval will have a width of 0.26 (0.77 - 1.03). The number (32) also reflects the number of cases that we expect to recruit over a 2-3 year period.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients having pre-operative DTT prior to surgery | Experimental | Diagnostic Test: Probabilistic diffusion tensor tractographyAll patients in this study will undergo DTT as part of a pre-operative MRI. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- The capacity to understand the patient information sheet and the ability to provide written informed consent
- >1.5cm extrameatal tumor determined to represent a vestibular schwannoma by preoperative imaging
- HB grade I or II preoperatively
Key exclusion criteria (3 listed)
- Patients not meeting the above inclusion criteria
- Standard contraindications to MRI
- Previous cranial radiotherapy or previous surgery to the cerebellopontine angle cistern or IAM
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Probabilistic diffusion tensor tractographyPatients enrolled in this study will undergo probabilistic diffusion tensor tractography (additional MRI sequence) preoperatively in order to determine whether this it is possible to determine the course of the facial nerve. | Diagnostic test | Patients having pre-operative DTT prior to surgery |
Primary outcome
Accuracy of probabilistic diffusion tensor tractography (DTT)
Time frame: 4 years
To assess the accuracy of pre-operative probabilistic DTT in determining the position of the facial nerve (relative to extrameatal portion of a vestibular schwannoma) by using the facial nerve position at surgery as a reference standard.
6 secondary outcomes
Reproducibility
Time frame: 4 years
Relationship of tumour size with confidence
Time frame: 4 years
Relationship of tumour size with accuracy
Time frame: 4 years
Facial nerve shape
Time frame: 4 years
Comparison of DTT with conventional anatomical sequence
Time frame: 4 years
Assessment of adjacent CPA nerves.
Time frame: 4 years
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Sep 2025.
- Background: PubMed 23883249Cauley KA, Filippi CG. Diffusion-tensor imaging of small nerve bundles: cranial nerves, peripheral nerves, distal spinal cord, and lumbar nerve roots--clinical applications. AJR Am J Roentgenol. 2013 Aug;201(2):W326-35. doi: 10.2214/AJR.12.9230.
- Background: PubMed 25289119Choi KS, Kim MS, Kwon HG, Jang SH, Kim OL. Preoperative identification of facial nerve in vestibular schwannomas surgery using diffusion tensor tractography. J Korean Neurosurg Soc. 2014 Jul;56(1):11-5. doi: 10.3340/jkns.2014.56.1.11. Epub 2014 Jul 31.
- Background: PubMed 21962081Gerganov VM, Giordano M, Samii M, Samii A. Diffusion tensor imaging-based fiber tracking for prediction of the position of the facial nerve in relation to large vestibular schwannomas. J Neurosurg. 2011 Dec;115(6):1087-93. doi: 10.3171/2011.7.JNS11495. Epub 2011 Aug 26.
- Background: PubMed 18339720Mukherjee P, Berman JI, Chung SW, Hess CP, Henry RG. Diffusion tensor MR imaging and fiber tractography: theoretic underpinnings. AJNR Am J Neuroradiol. 2008 Apr;29(4):632-41. doi: 10.3174/ajnr.A1051. Epub 2008 Mar 13.
- Background: PubMed 10616085Sampath P, Rini D, Long DM. Microanatomical variations in the cerebellopontine angle associated with vestibular schwannomas (acoustic neuromas): a retrospective study of 1006 consecutive cases. J Neurosurg. 2000 Jan;92(1):70-8. doi: 10.3171/jns.2000.92.1.0070.
- Background: PubMed 26722859Song F, Hou Y, Sun G, Chen X, Xu B, Huang JH, Zhang J. In vivo visualization of the facial nerve in patients with acoustic neuroma using diffusion tensor imaging-based fiber tracking. J Neurosurg. 2016 Oct;125(4):787-794. doi: 10.3171/2015.7.JNS142922. Epub 2016 Jan 1.
- Background: PubMed 17031835Taoka T, Hirabayashi H, Nakagawa H, Sakamoto M, Myochin K, Hirohashi S, Iwasaki S, Sakaki T, Kichikawa K. Displacement of the facial nerve course by vestibular schwannoma: preoperative visualization using diffusion tensor tractography. J Magn Reson Imaging. 2006 Nov;24(5):1005-10. doi: 10.1002/jmri.20725.
- Background: PubMed 27915063Zhang Y, Mao Z, Wei P, Jin Y, Ma L, Zhang J, Yu X. Preoperative Prediction of Location and Shape of Facial Nerve in Patients with Large Vestibular Schwannomas Using Diffusion Tensor Imaging-Based Fiber Tracking. World Neurosurg. 2017 Mar;99:70-78. doi: 10.1016/j.wneu.2016.11.110. Epub 2016 Nov 30.
- Background: PubMed 28754643Zolal A, Juratli TA, Podlesek D, Rieger B, Kitzler HH, Linn J, Schackert G, Sobottka SB. Probabilistic Tractography of the Cranial Nerves in Vestibular Schwannoma. World Neurosurg. 2017 Nov;107:47-53. doi: 10.1016/j.wneu.2017.07.102. Epub 2017 Jul 25.
- Individual participant dataSharing planned: No
Related trials for Vestibular Schwannoma
Enrolling by invitationObservational study
Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy
Vestibular Schwannoma
RecruitingPhase 1/2
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
Vestibular Schwannoma
Not yet recruitingPhase 2
Selumetinib for NF2-Related Schwannomatosis
Neurofibromatosis Type 2, NF2
RecruitingPhase 2
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Neurofibromatosis Type 2, Vestibular Schwannoma
RecruitingPhase 3
Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients
Vestibular Schwannoma, Facial Nerve Paralysis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Steve Connor, MBBS, FRCR principal investigator
King's College Hospital NHS Trust
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Probabilistic diffusion tensor tractography in people with Vestibular Schwannoma, run by King's College Hospital NHS Trust at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Accuracy of probabilistic diffusion tensor tractography (DTT) (time frame: 4 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04057976, which also lists 9 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Sep 2025.